You are using an outdated browser. Please upgrade your browser to improve your experience.
SpeechAssess

Our App is a closed, participant-only, research study with the intent to gather data for motor neuron degenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, and others

Our App is a closed, participant-only, research study with the intent to gather data for motor neuron degenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, and others

SpeechAssess

by Aural Analytics
SpeechAssess
SpeechAssess
SpeechAssess

What is it about?

Our App is a closed, participant-only, research study with the intent to gather data for motor neuron degenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, and others. For now, the functionality of the application is limited to speech data collection. We will disseminate this app to over 60 clinical sites to collect an initial set of data for analysis on the back-end. Eventually, the functionality of the app will be expanded to include outcome measures that track patient progress; however in order to do this, the app must be disseminated in its current form in order to collect data for algorithm calibration.

SpeechAssess

App Details

Version
1.9997
Rating
NA
Size
7Mb
Genre
Medical
Last updated
December 22, 2019
Release date
April 13, 2017
More info

App Screenshots

SpeechAssess screenshot-0
SpeechAssess screenshot-1
SpeechAssess screenshot-2
SpeechAssess screenshot-3

App Store Description

Our App is a closed, participant-only, research study with the intent to gather data for motor neuron degenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, and others. For now, the functionality of the application is limited to speech data collection. We will disseminate this app to over 60 clinical sites to collect an initial set of data for analysis on the back-end. Eventually, the functionality of the app will be expanded to include outcome measures that track patient progress; however in order to do this, the app must be disseminated in its current form in order to collect data for algorithm calibration.

Our participants' locations are nationwide (over 60 sites). We have developed the application specifically for the iPad and will purchase 60 iPads to distribute for this study alone. It is our hope to do additional studies in the future with this App.

Distribution of the App, and future updates, becomes non-trivial if we are required to disseminate the app outside of the Apple App Store. Our intent is to make this research study as simple as possible for these participants with these diseases. The research study is partially funded by the National Science Foundation (NSF) and the National Institutes of Health (NIH) and has the potential to transform the way that outcomes are measured in populations with neurodegenerative disorders.

Initially this App will be used by specific clinics and research institutions to administer tests these tests to patients in a controlled environment. Later, we will release a "home version" to gather data from patients without a clinical visit.

For more information, contact us at:

http://www.AuralAnalytics.com
support@auralanalytics.com
(480) 630-8575

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.